# Mag Assist

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mag-assist

- Industry: Healthcare
- Headquarters: Suzhou, China
- Website: www.magassist.com.cn
- Total disclosed funding: $78M
- Latest round: Series C (Oct 18, 2021)
- Investors on record: 10

## About

Based in Suzhou, China and established in 2017, Mag Assist is a medical device developer that provides short and medium-term artificial heart devices.

The company provides life saving technology and service for our patients and clinicians. The company focuses on patients with acute cardiogenic shock, circulatory protection during cardiac surgery and acute and severe organ failure. The company adopts mechatronics, magnetic levitation and computational fluid dynamics technology. The product pipeline of the company includes interventional artificial heart, external magnetic suspension artificial heart, a new generation of extracorporeal membrane oxygenation (ECMO).

The company will increase investment in researching and developing product and clinical trials and expand production scale.

## Funding rounds

- Series C, Oct 18, 2021, $78M — Hong Shan, CDH Investments, Cenova Ventures
- Series B, Jan 11, 2021 — NLVC, Guoqian Venture Capital, TigerYeah Capital, Anji Yunshuo
- Series A, Jul 4, 2019 — MED-FINE Capital, Huatai Zijin Investment, Qianshan Capital, Guoqian Venture Capital

## Investors

- MED-FINE Capital (https://capitalatlas.ai/funds/med-fine-capital) — Series A
- Huatai Zijin Investment (https://capitalatlas.ai/funds/huatai-zijin-investment) — Series A
- Qianshan Capital — Series A
- Guoqian Venture Capital (https://capitalatlas.ai/funds/guoqian-venture-capital) — Series A, Series B
- NLVC (https://capitalatlas.ai/funds/nlvc) — Series B
- TigerYeah Capital (https://capitalatlas.ai/funds/tigeryeah-capital) — Series B
- Anji Yunshuo — Series B
- Hong Shan — Series C
- CDH Investments (https://capitalatlas.ai/funds/cdh-investments) — Series C
- Cenova Ventures (https://capitalatlas.ai/funds/cenova-ventures) — Series C